ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,724.30
-0.33%
S&P ASX All Technology
3,092.70
-1.13%
Brent Oil
82.36
0.47%
US Dollar vs AUD
1.51204
0.29%
Bitcoin
65,525.46
-1.84%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Bionano Genomics Inc (BNGO)

  7. Bionano Genomics Inc (BNGO) News

BNGO Bionano Genomics Inc

0.83
-0.014 (-1.66%)
Last Updated: 05:12:47
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Bionano Genomics Inc BNGO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.014 -1.66% 0.83 05:12:47
Open Price Low Price High Price Close Price Previous Close
0.8324 0.82 0.849899 0.844
more quote information »

Recent News

Date Time Source Heading
11/6/202407:12EDGAR2Form S-3 - Registration statement under Securities Act of..
06/6/202407:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202407:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202407:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202407:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202407:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202404:59EDGAR2Form D - Notice of Exempt Offering of Securities
30/5/202422:00GLOBEBionano Announces Robust Presence at Upcoming Cytogenetics..
28/5/202422:15EDGAR2Form 8-K - Current report
28/5/202422:00GLOBEBionano Announces Private Placement of Senior Secured Notes..
21/5/202422:00GLOBEBionano Announces Three Publications Demonstrating OGM’s..
09/5/202422:00GLOBEBionano Announces Series of Major Advancements to its Suite..
09/5/202407:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/5/202406:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202406:02EDGAR2Form 8-K - Current report
09/5/202406:01GLOBEBionano Reports First Quarter 2024 Results and Highlights..
01/5/202422:00GLOBEBionano to Report First Quarter 2024 Financial Results and..
01/5/202406:05GLOBEBionano to Present at the RBC Capital Markets 2024 Global..
24/4/202422:00GLOBEBionano Announces Publication Showing OGM’s High Resolution..
17/4/202422:00GLOBEBionano and Diagens Sign Partnership to Commercialize the..
11/4/202422:00GLOBEBionano Announces Publication Showing that OGM Detects Over..
05/4/202404:44GLOBEBionano Announces $10 Million Registered Direct Offering..
03/4/202423:00GLOBEBionano Announces Publication Showing that OGM Identifies..
02/4/202423:00GLOBEBionano Announces 9 Poster Presentations and Introduces New..
19/3/202423:00GLOBEBionano Announces Publication of a Breast Cancer Study..
08/3/202400:00GLOBEBionano Announces Extensive Lineup of Content at American..
06/3/202409:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202409:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202409:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202409:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202409:26EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/3/202408:23EDGAR2Form 8-K - Current report
06/3/202408:01GLOBEBionano Reports Fourth Quarter and Full-Year 2023 Results..
01/3/202400:00GLOBEBionano to Present at TD Cowen’s 44th Annual Health Care..
29/2/202400:16EDGAR2Form 8-K - Current report
29/2/202400:01GLOBEBionano to Report Fourth Quarter and Year End 2023 Financial..
29/2/202400:00GLOBEBionano Announces Amendment to Debt Financing Arrangement to..
23/2/202400:00GLOBEAmerican College of Medical Genetics and Genomics Includes..
01/2/202400:00GLOBEBionano to Participate in the BTIG Snowbird MedTech, Digital..
31/1/202400:00GLOBEBionano’s Symposium 2024 Featured Presentations from its..
25/1/202400:00GLOBEBionano Announces Publication of Interim Readout from Second..
24/1/202400:00GLOBEBionano Announces Full Commercial Release of the Stratys™..
20/1/202400:00GLOBEBionano Announces the Final Speaker Lineup for 2024..
12/1/202408:01GLOBEBionano Announces Peer-Reviewed Publication from its..
11/1/202400:00GLOBEBionano Announces 2024 Symposium: Four Consecutive Days of..
09/1/202400:10EDGAR2Form 8-K - Current report
09/1/202400:00GLOBEBionano Reports Preliminary Fourth Quarter and Full-Year..
29/12/202300:00GLOBEBionano Announces Significant Upgrades to its Bionano Solve..
27/12/202300:00GLOBEBionano Announces Publication of Largest Prospective..
15/12/202300:00GLOBECancers Journal Publishes Special Issue Dedicated to OGM’s..

Your Recent History

NASDAQ
BNGO
Bionano Genomics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved